$PETV
PetVivo Holdings, Inc. Stock $petv

$petv Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-Q Financial Statement

#000149315224005908 Filed on February 12, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2022 Q4
Revenue	$48.27K	$595.9K	$510.1K
YoY Change	-61.57%	16.82%	900.21%
Cost Of Revenue	-$177.1K	$183.1K	$223.7K
YoY Change	-273.7%	-18.15%	125.95%
Gross Profit	$225.4K	$412.8K	$286.4K
YoY Change	852.9%	44.12%	-696.71%
Gross Profit Margin	466.87%	69.28%	56.15%
Selling, General & Admin	$2.302M	$2.315M	$2.357M
YoY Change	8.48%	-1.77%	49.62%
% of Gross Profit	1021.61%	560.89%	822.94%
Research & Development	$572.9K	$231.1K	$248.2K
YoY Change	148.66%	-6.89%	622.86%
% of Gross Profit	254.2%	55.97%	86.64%
Depreciation & Amortization	$33.16K	$28.29K	$31.04K
YoY Change	46.47%	-8.86%	100.48%
% of Gross Profit	14.71%	6.85%	10.84%
Operating Expenses	$2.875M	$2.546M	$2.605M
YoY Change	22.21%	-2.26%	61.85%
Operating Profit	-$2.650M	-$2.134M	-$2.319M
YoY Change	13.78%	-7.99%	39.89%
Interest Expense	-$1.920K	-$2.100K	$7.200K
YoY Change		-129.17%	-53.61%
% of Operating Profit
Other Income/Expense, Net		$383.8K	$7.200K
YoY Change		5230.22%	-53.61%
Pretax Income	-$2.651M	-$1.750M	-$2.312M
YoY Change	13.82%	-24.3%	40.77%
Income Tax
% Of Pretax Income
Net Earnings	-$2.651M	-$1.750M	-$2.312M
YoY Change	13.82%	-24.3%	40.77%
Net Earnings / Revenue	-5491.44%	-293.65%	-453.16%
Basic Earnings Per Share		-$0.12	-$0.23
Diluted Earnings Per Share	-$0.16	-$0.12	-$0.23
COMMON SHARES
Basic Shares Outstanding	16.77M shares	14.47M shares	10.10M shares
Diluted Shares Outstanding		14.27M shares	10.10M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$87.40K	$80.09K	$374.5K
YoY Change	-81.61%	-78.62%	-95.04%
Cash & Equivalents	$87.40K	$80.09K	$374.5K
Short-Term Investments
Other Short-Term Assets	$545.5K	$426.7K	$479.7K
YoY Change	10.95%	-11.05%	28.42%
Inventory	$390.1K	$467.5K	$374.9K
Prepaid Expenses	$545.5K
Receivables	$18.67K	$518.7K	$506.8K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$1.042M	$1.493M	$1.736M
YoY Change	-26.85%	-14.0%	-78.4%
LONG-TERM ASSETS
Property, Plant & Equipment	$821.7K	$823.3K	$520.3K
YoY Change	-13.4%	58.23%	27.8%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments		$27.49K	$12.83K
YoY Change		114.26%	0.0%
Other Assets	$27.49K	$27.49K
YoY Change
Total Long-Term Assets	$2.074M	$2.137M	$832.4K
YoY Change	104.3%	156.73%	80.67%
TOTAL ASSETS
Total Short-Term Assets	$1.042M	$1.493M	$1.736M
Total Long-Term Assets	$2.074M	$2.137M	$832.4K
Total Assets	$3.115M	$3.630M	$2.568M
YoY Change	27.73%	41.33%	-69.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$821.2K	$1.094M	$456.1K
YoY Change	39.5%	139.92%	73.23%
Accrued Expenses	$243.0K	$242.0K	$1.042M
YoY Change	-71.68%	-76.77%	25.05%
Deferred Revenue
YoY Change
Short-Term Debt	$157.5K	$129.8K	$6.840K
YoY Change	2169.74%	1796.93%	5.88%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.412M	$1.662M	$1.565M
YoY Change	-2.84%	6.23%	41.41%
LONG-TERM LIABILITIES
Long-Term Debt	$13.17K	$15.03K	$22.16K
YoY Change	-35.5%	-32.18%	-23.16%
Other Long-Term Liabilities	$1.004M	$1.058M	$197.4K
YoY Change	318.53%	435.71%	77.99%
Total Long-Term Liabilities	$1.017M	$1.073M	$219.6K
YoY Change	290.75%	388.51%	57.11%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.412M	$1.662M	$1.565M
Total Long-Term Liabilities	$1.017M	$1.073M	$219.6K
Total Liabilities	$2.429M	$2.735M	$1.784M
YoY Change	41.74%	53.28%	43.17%
SHAREHOLDERS EQUITY
Retained Earnings	-$82.80M	-$80.15M	-$69.52M
YoY Change	15.25%	15.3%
Common Stock	$17.06K	$14.92K	$10.11K
YoY Change	55.79%	47.64%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$686.0K	$895.1K	$784.2K
YoY Change
Total Liabilities & Shareholders Equity	$3.115M	$3.630M	$2.568M
YoY Change	27.73%	41.33%	-69.77%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2022 Q4
OPERATING ACTIVITIES
Net Income	-$2.651M	-$1.750M	-$2.312M
YoY Change	13.82%	-24.3%	40.77%
Depreciation, Depletion And Amortization	$33.16K	$28.29K	$31.04K
YoY Change	46.47%	-8.86%	100.48%
Cash From Operating Activities	-$1.524M	-$1.291M	-$1.751M
YoY Change	17.76%	-26.28%	19.47%
INVESTING ACTIVITIES
Capital Expenditures	$29.30K	$186.2K	$210.3K
YoY Change	-77.48%	-11.46%	-380.94%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$29.30K	-$186.2K	-$210.3K
YoY Change	-77.48%	-11.46%	180.94%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.561M	1.502M	-1.610K
YoY Change	2.34%	-93363.35%	-100.58%
NET CHANGE
Cash From Operating Activities	-1.524M	-1.291M	-1.751M
Cash From Investing Activities	-29.30K	-186.2K	-210.3K
Cash From Financing Activities	1.561M	1.502M	-1.610K
Net Change In Cash	7.310K	24.84K	-1.963M
YoY Change	-92.75%	-101.27%	55.3%
FREE CASH FLOW
Cash From Operating Activities	-$1.524M	-$1.291M	-$1.751M
Capital Expenditures	$29.30K	$186.2K	$210.3K
Free Cash Flow	-$1.553M	-$1.477M	-$1.961M
YoY Change	9.06%	-24.69%	41.03%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Litigation Settlement Expense LitigationSettlementExpense		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Entity Central Index Key EntityCentralIndexKey	0001512922
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	PETV	Common Stock To Be Issued CommonStockToBeIssued		usd
CY2023Q1	PETV	Common Stock Receivable CommonStockReceivable		usd
CY2023Q4	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Litigation Settlement Expense LitigationSettlementExpense		usd
CY2022Q4	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt		usd
	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt		usd
CY2023Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2023Q3	PETV	Stock Issued During Period Value Cashless Warrants Exercises StockIssuedDuringPeriodValueCashlessWarrantsExercises		usd
CY2023Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2023Q4	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2022Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2022Q4	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
	PETV	Consulting Services Paid In Stock ConsultingServicesPaidInStock		usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Interest Expense Subordinated Notes And Debentures InterestExpenseSubordinatedNotesAndDebentures		usd
	PETV	Extinguishment Of Payables ExtinguishmentOfPayables		usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet		usd
	PETV	Proceeds From Issuance Of Common Stock And Warrants ProceedsFromIssuanceOfCommonStockAndWarrants		usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	PETV	Convertible Debentures And Accrued Interest Converted To Common Stock ConvertibleDebenturesAndAccruedInterestConvertedToCommonStock		usd
	PETV	Increase To Operating Lease Right Of Use Asset And Operating Lease Liability IncreaseToOperatingLeaseRightOfUseAssetAndOperatingLeaseLiability		usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent		usd
CY2023Q4	PETV	Accrued Lease Termination Expense AccruedLeaseTerminationExpense		usd
CY2017Q2	us-gaap	Lessor Operating Lease Term Of Contract LessorOperatingLeaseTermOfContract	P84M
CY2023Q4	PETV	Base Rent Payments Included In Prepaid Expenses BaseRentPaymentsIncludedInPrepaidExpenses		usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-40715
	dei	Entity Registrant Name EntityRegistrantName	PetVivo Holdings, Inc
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	99-0363559
	dei	Entity Address Address Line1 EntityAddressAddressLine1	5251 Edina Industrial Blvd.
	dei	Entity Address City Or Town EntityAddressCityOrTown	Edina
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MN
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	55439
	dei	City Area Code CityAreaCode	(952)
	dei	Local Phone Number LocalPhoneNumber	405-6216
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	16770018	shares
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	80085	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	475314	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	518686	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	86689	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	467467	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	370283	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	426646	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	491694	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	1492884	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	1423980	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	823280	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	630852	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1253815	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	317981	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	32333	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	38649	usd
CY2023Q4	us-gaap	Security Deposit SecurityDeposit	27490	usd
CY2023Q1	us-gaap	Security Deposit SecurityDeposit	27490	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	1313638	usd
CY2023Q1	us-gaap	Other Assets OtherAssets	384120	usd
CY2023Q4	us-gaap	Assets Assets	3629802	usd
CY2023Q1	us-gaap	Assets Assets	2438952	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1094152	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	588713	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	241959	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	779882	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	196263	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	78149	usd
CY2023Q4	PETV	Notes Payable And Accrued Interest Current NotesPayableAndAccruedInterestCurrent	129746	usd
CY2023Q1	PETV	Notes Payable And Accrued Interest Current NotesPayableAndAccruedInterestCurrent	6936	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1662120	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	1453680	usd
CY2023Q4	PETV	Notes Payable And Accrued Interest Non Current NotesPayableAndAccruedInterestNonCurrent	15030	usd
CY2023Q1	PETV	Notes Payable And Accrued Interest Non Current NotesPayableAndAccruedInterestNonCurrent	20415	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1057552	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	239832	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1072582	usd
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	260247	usd
CY2023Q4	us-gaap	Liabilities Liabilities	2734702	usd
CY2023Q1	us-gaap	Liabilities Liabilities	1713927	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14921209	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14921209	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10950220	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10950220	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	14921	usd
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	10950	usd
CY2023Q1	PETV	Common Stock To Be Issued CommonStockToBeIssued	137500	usd
CY2023Q4	PETV	Common Stock Receivable CommonStockReceivable	-27000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	81055786	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	72420604	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-80148607	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-71844029	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	895100	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	725025	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3629802	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2438952	usd
CY2023Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	595891	usd
CY2022Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	510109	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	920440	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	791563	usd
CY2023Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	183087	usd
CY2022Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	223687	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	406270	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	424866	usd
CY2023Q4	us-gaap	Gross Profit GrossProfit	412804	usd
CY2022Q4	us-gaap	Gross Profit GrossProfit	286422	usd
	us-gaap	Gross Profit GrossProfit	514170	usd
	us-gaap	Gross Profit GrossProfit	366697	usd
CY2023Q4	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1032575	usd
CY2022Q4	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1047549	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3053184	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2572103	usd
CY2023Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	231066	usd
CY2022Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	248157	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	695156	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	460197	usd
CY2023Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1282787	usd
CY2022Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1309534	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4737374	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3738876	usd
CY2023Q4	us-gaap	Operating Expenses OperatingExpenses	2546428	usd
CY2022Q4	us-gaap	Operating Expenses OperatingExpenses	2605240	usd
	us-gaap	Operating Expenses OperatingExpenses	8485714	usd
	us-gaap	Operating Expenses OperatingExpenses	6771176	usd
CY2023Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-2133624	usd
CY2022Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-2318818	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-7971544	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-6404479	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-534366	usd
	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	180000	usd
CY2023Q4	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt	385874	usd
	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt	385874	usd
CY2023Q4	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-2098	usd
CY2022Q4	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	7200	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-4542	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	15844	usd
CY2023Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	383776	usd
CY2022Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	7200	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-333034	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	15844	usd
CY2023Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1749848	usd
CY2022Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2311618	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8304578	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6388635	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-1749848	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-2311618	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8304578	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6388635	usd
CY2023Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2023Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.23
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.23
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.64
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.64
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.64
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.64
CY2023Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14271530	shares
CY2023Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14271530	shares
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10098658	shares
CY2022Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10098658	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12976851	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12976851	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10047040	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10047040	shares
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	725025	usd
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1956094	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	123078	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	413030	usd
CY2023Q2	PETV	Stock Issued During Period Value Vesting Of Restricted Stock Units In Lieu Of Compensation StockIssuedDuringPeriodValueVestingOfRestrictedStockUnitsInLieuOfCompensation	74589	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-2893577	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	398239	usd
CY2023Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1775782	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	740978	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	577500	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	509310	usd
CY2023Q3	PETV	Stock Issued During Period Value Vesting Of Restricted Stock Units In Lieu Of Compensation StockIssuedDuringPeriodValueVestingOfRestrictedStockUnitsInLieuOfCompensation	41006	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	607017	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-3661153	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	988679	usd
CY2023Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1383254	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	293125	usd
CY2023Q4	PETV	Stock Issued During Period Value Return Of Stock Issued For Services StockIssuedDuringPeriodValueReturnOfStockIssuedForServices	-537500	usd
CY2023Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	517390	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-1749848	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	895100	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	5986722	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	231231	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-1965428	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	4252525	usd
CY2022Q3	PETV	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	66558	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	49920	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	305971	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-2111589	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	2563385	usd
CY2022Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	532383	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-2311618	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	784150	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	784150	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8304578	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6388635	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1537437	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1069585	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	93691	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	91785	usd
	PETV	Investor Relations Services Paid In Stock InvestorRelationsServicesPaidInStock	289913	usd
	PETV	Investor Relations Services Paid In Stock InvestorRelationsServicesPaidInStock	258844	usd
	PETV	Consulting Services Paid In Stock ConsultingServicesPaidInStock	339641	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	115595	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-534366	usd
	us-gaap	Interest Expense Subordinated Notes And Debentures InterestExpenseSubordinatedNotesAndDebentures	2444	usd
	PETV	Extinguishment Of Payables ExtinguishmentOfPayables	385874	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-55174	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	140930	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	431997	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	504248	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	97184	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	276569	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	353390	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	389921	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	2498	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5895484	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5500247	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	279802	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	293851	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-279802	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-293851	usd
	PETV	Proceeds From Issuance Of Common Stock And Warrants ProceedsFromIssuanceOfCommonStockAndWarrants	5115130	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	550000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	120000	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	66558	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	5073	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	4754	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5780057	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	61804	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-395229	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-5732294	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	475314	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6106827	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	80085	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	374533	usd
	us-gaap	Interest Paid Net InterestPaidNet	1224	usd
	us-gaap	Interest Paid Net InterestPaidNet	2388	usd
	PETV	Convertible Debentures And Accrued Interest Converted To Common Stock ConvertibleDebenturesAndAccruedInterestConvertedToCommonStock	577500	usd
	PETV	Prepaid Stock Issued For Services PrepaidStockIssuedForServices	280040	usd
	PETV	Prepaid Stock Issued For Services PrepaidStockIssuedForServices	49920	usd
	PETV	Increase To Operating Lease Right Of Use Asset And Operating Lease Liability IncreaseToOperatingLeaseRightOfUseAssetAndOperatingLeaseLiability	1081204	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2023Q4	PETV	Lease Termination Liability Payable LeaseTerminationLiabilityPayable	332238	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84C_eus-gaap--UseOfEstimates_z7bhgCNITt4i" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><i>(D) <span id="xdx_86C_zJgq8GARZ69b">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">In preparing financial statements in conformity with generally accepted accounting principles, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include collectability of accounts receivable, inventory obsolescence, estimated useful lives and potential impairment of property and equipment and intangibles, estimate of fair value of share-based payments, distributor rebate payable, provision for product returns, right of use lease assets and liabilities and valuation of deferred tax assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p>
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_847_eus-gaap--ConcentrationRiskCreditRisk_z1PP2U60NZV7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><i>(F) <span id="xdx_86E_zx4vuFbEgGI8">Concentration Risk</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">The Company maintains its cash with various financial institutions, which at times may exceed federally insured limits. At December 31, 2023, the Company did not have cash balances in excess of the federally insured limits.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p>
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2023Q4	us-gaap	Inventory Adjustments InventoryAdjustments	0	usd
CY2023Q1	us-gaap	Inventory Adjustments InventoryAdjustments	0	usd
	PETV	Distribution Fee Payable Percentage DistributionFeePayablePercentage	0.05	pure
CY2023Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	409032	usd
CY2023Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	81510	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	57264	usd
CY2023Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	28000	usd
CY2023Q4	PETV	Distribution Fee Payable DistributionFeePayable	39026	usd
CY2023Q1	PETV	Distribution Fee Payable DistributionFeePayable	5187	usd
CY2023Q4	us-gaap	Fair Value Net Asset Liability FairValueNetAssetLiability	0	usd
CY2023Q1	us-gaap	Fair Value Net Asset Liability FairValueNetAssetLiability	0	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	467467	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	370283	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	102177	usd
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	13159	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	20289	usd
CY2023Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	53398	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	345001	usd
CY2023Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	303726	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	467467	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	370283	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	426646	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	491694	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1219944	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	940142	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	396664	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	309290	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	823280	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	630852	usd
CY2023Q4	us-gaap	Depreciation Depreciation	28286	usd
CY2022Q4	us-gaap	Depreciation Depreciation	28719	usd
	us-gaap	Depreciation Depreciation	87374	usd
	us-gaap	Depreciation Depreciation	54044	usd
CY2023Q4	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	3870057	usd
CY2023Q1	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	3870057	usd
CY2023Q4	us-gaap	Finite Lived Trademarks Gross FiniteLivedTrademarksGross	26142	usd
CY2023Q1	us-gaap	Finite Lived Trademarks Gross FiniteLivedTrademarksGross	26142	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3896199	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3896199	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3863866	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3857550	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	32333	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	38649	usd
CY2023Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2041	usd
CY2022Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2227	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6316	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4466	usd
CY2023Q4	PETV	Accrued Expenses Current AccruedExpensesCurrent	241959	usd
CY2023Q1	PETV	Accrued Expenses Current AccruedExpensesCurrent	188666	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	258978	usd
CY2023Q1	PETV	Accrued Lease Termination Expense AccruedLeaseTerminationExpense	332238	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	241959	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	779882	usd
CY2023Q1	PETV	Lease Termination Liability Payable LeaseTerminationLiabilityPayable	332238	usd
CY2023Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	53636	usd
	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount	385874	usd
CY2020Q1	us-gaap	Notes Payable NotesPayable	42500	usd
CY2020Q1	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.06	pure
CY2023Q4	us-gaap	Notes Payable NotesPayable	22278	usd
CY2023Q1	us-gaap	Notes Payable NotesPayable	27351	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	7248	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	15030	usd
CY2023Q1	us-gaap	Notes Payable Current NotesPayableCurrent	6936	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	20415	usd
CY2023Q4	us-gaap	Notes Payable NotesPayable	120000	usd
CY2023Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.10	pure
CY2023Q4	us-gaap	Debt Instrument Maturity Date Description DebtInstrumentMaturityDateDescription	February 2024
CY2023Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	2498	usd
	us-gaap	Common Stock Conversion Basis CommonStockConversionBasis	The holder of the note has the option to convert the principal and accrued interest into shares of the Company’s common stock at a conversion rate of $0.75 per share
CY2023Q4	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	12014	usd
CY2022Q4	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	8183	usd
	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	37422	usd
	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	14341	usd
CY2017Q2	us-gaap	Area Of Land AreaOfLand	3577	sqft
CY2017Q2	PETV	Percentage Of Increase In Rent PercentageOfIncreaseInRent	0.02	pure
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	49104	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	199956	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	203898	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	181434	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	114410	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	114273	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	518517	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1381592	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	127777	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1253815	usd
	us-gaap	Lessee Operating Lease Option To Extend LesseeOperatingLeaseOptionToExtend	the extended lease terms to June 2026, November 2026, March 2027, and June 2033
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y7M6D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0405	pure
CY2023Q4	PETV	Operating Lease Liability Gross OperatingLeaseLiabilityGross	1253815	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1253815	usd
CY2023Q4	PETV	Operating Lease Rightofuse Current Asset OperatingLeaseRightofuseCurrentAsset	1253815	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1253815	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	196263	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1057552	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1253815	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8304578	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5895484	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-80148607	usd
	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	509310	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	145820	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	171180	usd
CY2023Q2	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	793585	shares
CY2023Q2	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	2182359	usd
CY2023Q2	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	88765	usd
CY2023Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	2.75
CY2023Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	137500	usd
CY2023Q3	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	1200002	shares
CY2023Q3	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	1775782	usd
CY2023Q3	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	24218	usd
CY2023Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	1.50
CY2023Q4	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	125000	shares
CY2023Q4	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	200000	usd
CY2023Q4	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	250000	shares
CY2023Q4	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	537500	usd
CY2023Q4	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	600000	shares
CY2023Q4	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	870000	usd
CY2023Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	63107	usd
CY2023Q4	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	806893	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	255305	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	23747	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	14071	usd
CY2023Q4	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	352224	shares
CY2023Q4	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	290000	usd
CY2023Q4	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	74000	shares
CY2023Q4	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	89033	usd
CY2023Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	2672	usd
CY2023Q4	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	86361	usd
CY2023Q4	PETV	Amortization Of Stock Issued For Services AmortizationOfStockIssuedForServices	124103	usd
CY2022Q4	PETV	Amortization Of Stock Issued For Services AmortizationOfStockIssuedForServices	108794	usd
	PETV	Amortization Of Stock Issued For Services AmortizationOfStockIssuedForServices	289913	usd
	PETV	Amortization Of Stock Issued For Services AmortizationOfStockIssuedForServices	258844	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P7Y
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P7Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.759	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.956	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	1.117	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	1.469	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0346	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0448	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0296	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0435	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	195000	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.56
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y10M24D
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	100200	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	714849	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.37
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	25000	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.46
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	884849	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.19
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y3M18D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	307750	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	664939	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.88
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	20000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.99
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1529788	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.06
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y10M24D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	466084	shares
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	709394	shares
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	195000	shares
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	1063704	shares
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	709394	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	466084	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	175455	shares
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	2.23
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	1.56
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	1.95
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	2.23
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	2.31
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	2.01
CY2023Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	2317226	shares
CY2023Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	517390	usd
CY2022Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	305971	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1653032	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1069585	usd

Files In Submission

Name	View Source	Status
0001493152-24-005908-index-headers.html	Edgar Link	pending
0001493152-24-005908-index.html	Edgar Link	pending
0001493152-24-005908.txt	Edgar Link	pending
0001493152-24-005908-xbrl.zip	Edgar Link	pending
ex10-1.htm	Edgar Link	pending
ex10-2.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
petv-20231231.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
petv-20231231_def.xml	Edgar Link	unprocessable
petv-20231231_lab.xml	Edgar Link	unprocessable
petv-20231231_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
petv-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PETV
PetVivo Holdings, Inc. Stock $petv

2024 Q1 Form 10-Q Financial Statement

#000149315224005908 Filed on February 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PETV PetVivo Holdings, Inc. Stock $petv

2024 Q1 Form 10-Q Financial Statement

#000149315224005908 Filed on February 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PETV
PetVivo Holdings, Inc. Stock $petv